AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS
PR Newswire•26/10/2026•17:52 ET
0
Key Highlights
- ➤David W. Gibbs appointed immediately to Amgen’s board of directors
- ➤Gibbs joins Amgen’s Audit and Compensation and Management Development committees
- ➤Amgen board expands to 13 directors, including 12 independent members
- ➤Gibbs led Yum! Brands as CEO from 2020 to 2025
Expert Statements
Robert A. Bradway, Chairman and chief executive officer at Amgen
“We are excited to welcome David to Amgen's Board. David has a proven track record leading some of the world's most recognized consumer brands, and we look forward to benefiting from his expertise.”
Robert A. Bradway, Chairman and chief executive officer at Amgen
“His experience creating direct relationships with customers will help inform how we prepare for future launches and bring innovative treatments to more patients around the world.”
AMGEN APPOINTS DAVID W. GIBBS TO BOARD OF DIRECTORS PR Newswire
THOUSAND OAKS, Calif., Oct. 26, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of David W. Gibbs to its Board of Directors, effective immediately. Gibbs will serve on the Board's Audit Committee and Compensation and Management Development Committee.
Get started
Create a free account to read the full story.